SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Kirk's Market Thoughts -- Ignore unavailable to you. Want to Upgrade?


To: robert b furman who wrote (21237)11/4/2024 9:25:48 PM
From: sandeep1 Recommendation

Recommended By
berniel

  Read Replies (1) | Respond to of 27110
 
It is very difficult. I don’t think Trump gets it. It is not about him. It is about the future of the country. He couldn’t control his ego for the future of the country! Watch this - m.youtube.com

Depressing if dems win.



To: robert b furman who wrote (21237)11/4/2024 10:46:10 PM
From: Kirk ©1 Recommendation

Recommended By
Investor2

  Respond to of 27110
 
STAX has turned up.

Monthly summary

More clients were net buyers of equities than net sellers during the October STAX period pushing the STAX score slightly higher to 48.37, a gain of 2.7%. Interestingly, on a dollar basis, however, clients continued to rotate out of individual equities and into ETFs, mutual funds, and fixed income securities, suggesting the trend toward diversification and de-risking continues, though not to the same degree as the previous month. The STAX score this period was also more tightly correlated with the S&P 500 than last period when we saw a major divergence between the two. This could indicate the shedding of the higher beta and higher volatility names—which was prevalent during the September STAX period—has subsided and given way to a neutral to slightly bullish tone this past month.
Perhaps our capx stocks that are still way down from their peaks are about to benefit. If I wasn't so busy with the remodel, I'd like to look at charting my STAX data vs LRCX, AMAT and a few others like FDX and even Pfizer.



more at schwab.com